Single-arm study | Effects of CAR-T therapy in children with relapsed or refractory high-risk neuroblastoma

GD2-CART01 for Relapsed or Refractory High-Risk Neuroblastoma – New England Journal of Medicine (link to abstract – $ for full-text)

Commentary: CAR-T Therapy Helps Kids Battling Deadly Nervous System Tumors – HealthDay

Commentary on Twitter

Patients with neuroblastoma received CAR-positive T cells targeting a disialoganglioside. Of 63% with a response, 33% had a complete response (some durable). Cytokine release syndrome was common. https://t.co/LDaIoeGfV7

Read the science behind the study: https://t.co/L4D5x1G6BF pic.twitter.com/VfsQKfSVFf

— NEJM (@NEJM) April 5, 2023